Announcing our Series A: Building the AWS x Github For Biocomputing
Summary
LatchBio announced a $28 million Series A led by Coatue and Lux Capital. The company is building a software platform for biocomputing that combines no-code tools, managed cloud infrastructure, and collaborative data workflows. The post explains how the product helps biologists and bioinformaticians process complex experimental data with reproducible, versioned execution. It also highlights customer adoption across biotech companies and academic researchers, and says the new capital will accelerate product development and expansion.
Funding
Amount
$28.0M
Total raised
Date
June 2, 2022
Announcement date
Investors
Hummingbird Ventures, Caffeinated Capital, Coatue Management, Fifty Years Fund, Haystack Fund, Lux Capital
Lead investors
Company
latch.bio
Funded company
Classifications
industries
No industries detected
applications
Data Management
AskAI Classifications
Labels
SaaS
Bioinformatics Software
Data Management Software
Linked Companies
LatchBio
$1M to $5M